TABLE 3.
Candidate drug | Neomycin dose given after pretreatment | |||
---|---|---|---|---|
0 | 100 | 200 | 400 | |
No pretreatment | 100 ± 10 | 37 ± 20 | 20 ± 10 | 13 ± 7 |
Amsacrine | 100 ± 15 | 83 ± 13* | 93 ± 10* | 77 ± 17* |
Carvedilol | 100 ± 10 | 110 ± 17* | 90 ± 13* | 80 ± 20* |
Cepharanthine | 100 ± 11 | 100 ± 27* | 87 ± 30* | 97 ± 13* |
Drofenine | 100 ± 13 | 67 ± 20* | 70 ± 13* | 60 ± 13* |
Hexamethyleneamiloride | 100 ± 11 | 90 ± 30* | 80 ± 20* | 73 ± 20* |
Phenoxybenzamine | 100 ± 10 | 63 ± 7* | 67 ± 10* | 60 ± 13* |
Tacrine | 100 ± 12 | 80 ± 20* | 87 ± 13* | 67 ± 13* |
Zebrafish were pretreated with highest nontoxic dose of protective drug (100 μM cepharanthine, 50 μM drofenine, 50 μM tacrine, 50 μM carvedilol, 50 μM amsacrine, 50 μM hexamethyleneamiloride, and 50 μM phenoxybenzamine)
*p < 0.01 denotes statistically significant difference compared to control, two-way ANOVA